Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia

Abstract The COVID-19 crisis has had profound impacts on health service provision, particularly those providing client facing services. Supervised injecting facilities and drug consumption rooms across the world have been particularly challenged during the pandemic, as have their client group—people...

Full description

Bibliographic Details
Main Authors: Amanda Roxburgh, Marianne Jauncey, Carolyn Day, Mark Bartlett, Shelley Cogger, Paul Dietze, Suzanne Nielsen, Julie Latimer, Nico Clark
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Harm Reduction Journal
Subjects:
Online Access:https://doi.org/10.1186/s12954-021-00471-x
id doaj-7d264e39b9a34bf597c7af4598112b0e
record_format Article
spelling doaj-7d264e39b9a34bf597c7af4598112b0e2021-02-21T12:05:26ZengBMCHarm Reduction Journal1477-75172021-02-0118111010.1186/s12954-021-00471-xAdapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in AustraliaAmanda Roxburgh0Marianne Jauncey1Carolyn Day2Mark Bartlett3Shelley Cogger4Paul Dietze5Suzanne Nielsen6Julie Latimer7Nico Clark8Health Risks Program, Burnet InstituteDiscipline of Addiction Medicine, the Central Clinical School, Sydney Medical School, the Faculty of Medicine and Health, University of SydneyDiscipline of Addiction Medicine, the Central Clinical School, Sydney Medical School, the Faculty of Medicine and Health, University of SydneyUniting Medically Supervised Injecting CentreNorth Richmond Community Health Medically Supervised Injecting RoomHealth Risks Program, Burnet InstituteHealth Risks Program, Burnet InstituteUniting Medically Supervised Injecting CentreNorth Richmond Community Health Medically Supervised Injecting RoomAbstract The COVID-19 crisis has had profound impacts on health service provision, particularly those providing client facing services. Supervised injecting facilities and drug consumption rooms across the world have been particularly challenged during the pandemic, as have their client group—people who consume drugs. Several services across Europe and North America closed due to difficulties complying with physical distancing requirements. In contrast, the two supervised injecting facilities in Australia (the Uniting Medically Supervised Injecting Centre—MSIC—in Sydney and the North Richmond Community Health Medically Supervised Injecting Room—MSIR—in Melbourne) remained open (as at the time of writing—December 2020). Both services have implemented a comprehensive range of strategies to continue providing safer injecting spaces as well as communicating crucial health information and facilitating access to ancillary services (such as accommodation) and drug treatment for their clients. This paper documents these strategies and the challenges both services are facing during the pandemic. Remaining open poses potential risks relating to COVID-19 transmission for both staff and clients. However, given the harms associated with closing these services, which include the potential loss of life from injecting in unsafe/unsupervised environments, the public and individual health benefits of remaining open are greater. Both services are deemed ‘essential health services’, and their continued operation has important benefits for people who inject drugs in Sydney and Melbourne.https://doi.org/10.1186/s12954-021-00471-xHarm reductionSupervised injecting facilitiesDrug consumption roomsCOVID-19People who inject drugs
collection DOAJ
language English
format Article
sources DOAJ
author Amanda Roxburgh
Marianne Jauncey
Carolyn Day
Mark Bartlett
Shelley Cogger
Paul Dietze
Suzanne Nielsen
Julie Latimer
Nico Clark
spellingShingle Amanda Roxburgh
Marianne Jauncey
Carolyn Day
Mark Bartlett
Shelley Cogger
Paul Dietze
Suzanne Nielsen
Julie Latimer
Nico Clark
Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia
Harm Reduction Journal
Harm reduction
Supervised injecting facilities
Drug consumption rooms
COVID-19
People who inject drugs
author_facet Amanda Roxburgh
Marianne Jauncey
Carolyn Day
Mark Bartlett
Shelley Cogger
Paul Dietze
Suzanne Nielsen
Julie Latimer
Nico Clark
author_sort Amanda Roxburgh
title Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia
title_short Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia
title_full Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia
title_fullStr Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia
title_full_unstemmed Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia
title_sort adapting harm reduction services during covid-19: lessons from the supervised injecting facilities in australia
publisher BMC
series Harm Reduction Journal
issn 1477-7517
publishDate 2021-02-01
description Abstract The COVID-19 crisis has had profound impacts on health service provision, particularly those providing client facing services. Supervised injecting facilities and drug consumption rooms across the world have been particularly challenged during the pandemic, as have their client group—people who consume drugs. Several services across Europe and North America closed due to difficulties complying with physical distancing requirements. In contrast, the two supervised injecting facilities in Australia (the Uniting Medically Supervised Injecting Centre—MSIC—in Sydney and the North Richmond Community Health Medically Supervised Injecting Room—MSIR—in Melbourne) remained open (as at the time of writing—December 2020). Both services have implemented a comprehensive range of strategies to continue providing safer injecting spaces as well as communicating crucial health information and facilitating access to ancillary services (such as accommodation) and drug treatment for their clients. This paper documents these strategies and the challenges both services are facing during the pandemic. Remaining open poses potential risks relating to COVID-19 transmission for both staff and clients. However, given the harms associated with closing these services, which include the potential loss of life from injecting in unsafe/unsupervised environments, the public and individual health benefits of remaining open are greater. Both services are deemed ‘essential health services’, and their continued operation has important benefits for people who inject drugs in Sydney and Melbourne.
topic Harm reduction
Supervised injecting facilities
Drug consumption rooms
COVID-19
People who inject drugs
url https://doi.org/10.1186/s12954-021-00471-x
work_keys_str_mv AT amandaroxburgh adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia
AT mariannejauncey adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia
AT carolynday adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia
AT markbartlett adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia
AT shelleycogger adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia
AT pauldietze adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia
AT suzannenielsen adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia
AT julielatimer adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia
AT nicoclark adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia
_version_ 1724258516004241408